Caregen Gelecekteki Büyüme
Future kriter kontrolleri 2/6
Caregen is forecast to grow earnings and revenue by 14.1% and 11.1% per annum respectively. EPS is expected to grow by 14.2% per annum. Return on equity is forecast to be 18.7% in 3 years.
Anahtar bilgiler
14.1%
Kazanç büyüme oranı
14.2%
EPS büyüme oranı
Pharmaceuticals kazanç büyümesi | 38.2% |
Gelir büyüme oranı | 11.1% |
Gelecekteki özkaynak getirisi | 18.7% |
Analist kapsamı | Low |
Son güncelleme | 05 Aug 2024 |
Gelecekteki son büyüme güncellemeleri
Recent updates
Why We're Not Concerned Yet About Caregen Co., Ltd.'s (KOSDAQ:214370) 26% Share Price Plunge
Aug 06Caregen (KOSDAQ:214370) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Mar 18With Caregen Co., Ltd. (KOSDAQ:214370) It Looks Like You'll Get What You Pay For
Mar 05A Look At The Fair Value Of Caregen Co., Ltd. (KOSDAQ:214370)
Apr 20Here's How We Evaluate Caregen Co., Ltd.'s (KOSDAQ:214370) Dividend
Mar 02Caregen (KOSDAQ:214370) Is Growing Earnings But Are They A Good Guide?
Feb 04Do Its Financials Have Any Role To Play In Driving Caregen Co., Ltd.'s (KOSDAQ:214370) Stock Up Recently?
Jan 14Caregen Co., Ltd. (KOSDAQ:214370) Goes Ex-Dividend Soon
Dec 25Do Insiders Own Lots Of Shares In Caregen Co., Ltd. (KOSDAQ:214370)?
Dec 10Is Caregen Co., Ltd. (KOSDAQ:214370) A Great Dividend Stock?
Nov 19Kazanç ve Gelir Büyüme Tahminleri
Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
---|---|---|---|---|---|
12/31/2026 | 102,300 | 48,000 | 51,000 | 51,000 | 1 |
12/31/2025 | 96,400 | 44,000 | 44,000 | 44,000 | 1 |
12/31/2024 | 85,100 | 37,000 | 100,000 | 35,000 | 1 |
6/30/2024 | 77,067 | 33,894 | -52,842 | 21,176 | N/A |
3/31/2024 | 74,987 | 35,305 | -32,085 | -22,948 | N/A |
12/31/2023 | 79,210 | 39,930 | 18,902 | 28,603 | N/A |
9/30/2023 | 80,905 | 37,332 | -35,262 | -32,033 | N/A |
6/30/2023 | 80,498 | 33,814 | -25,972 | -22,947 | N/A |
3/31/2023 | 78,476 | 33,885 | 22,291 | 25,714 | N/A |
12/31/2022 | 69,098 | 27,267 | -30,706 | -27,681 | N/A |
9/30/2022 | 64,988 | 25,739 | 32,669 | 35,009 | N/A |
6/30/2022 | 60,327 | 26,018 | 29,230 | 31,259 | N/A |
3/31/2022 | 59,179 | 25,163 | 32,927 | 35,461 | N/A |
12/31/2021 | 59,088 | 25,318 | 46,590 | 51,859 | N/A |
9/30/2021 | 61,570 | 31,652 | 42,906 | 52,142 | N/A |
6/30/2021 | 62,639 | 31,579 | 29,332 | 45,743 | N/A |
3/31/2021 | 61,537 | 32,156 | 39,528 | 59,789 | N/A |
12/31/2020 | 60,295 | 31,478 | 8,956 | 30,776 | N/A |
9/30/2020 | 63,720 | 28,363 | 48,525 | 69,793 | N/A |
6/30/2020 | 63,817 | 28,356 | 53,702 | 70,422 | N/A |
3/31/2020 | 63,357 | 27,394 | 13,400 | 25,764 | N/A |
12/31/2019 | 64,699 | 28,070 | 62,294 | 69,659 | N/A |
9/30/2019 | 49,399 | 13,618 | 29,281 | 35,309 | N/A |
6/30/2019 | 46,897 | 12,120 | -7,510 | -4,399 | N/A |
3/31/2019 | 52,820 | 17,607 | 25,619 | 27,913 | N/A |
12/31/2018 | 51,211 | 16,491 | -9,612 | -6,821 | N/A |
9/30/2018 | 52,531 | 24,401 | -26,880 | -23,582 | N/A |
6/30/2018 | 51,965 | 24,556 | 35,807 | 39,192 | N/A |
3/31/2018 | 50,144 | 23,281 | N/A | 41,318 | N/A |
12/31/2017 | 46,531 | 18,426 | N/A | 47,879 | N/A |
9/30/2017 | 39,469 | 15,377 | N/A | 72,534 | N/A |
6/30/2017 | 34,784 | 11,412 | N/A | 31,868 | N/A |
3/31/2017 | 32,668 | 9,655 | N/A | -16,393 | N/A |
12/31/2016 | 30,905 | 11,569 | N/A | -15,958 | N/A |
6/30/2016 | 35,438 | 15,404 | N/A | -28,004 | N/A |
12/31/2015 | 30,234 | 12,811 | N/A | 1,957 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: A214370's forecast earnings growth (14.1% per year) is above the savings rate (2.6%).
Kazançlar ve Piyasa: A214370's earnings (14.1% per year) are forecast to grow slower than the KR market (29.3% per year).
Yüksek Büyüme Kazançları: A214370's earnings are forecast to grow, but not significantly.
Gelir ve Pazar: A214370's revenue (11.1% per year) is forecast to grow faster than the KR market (9.9% per year).
Yüksek Büyüme Geliri: A214370's revenue (11.1% per year) is forecast to grow slower than 20% per year.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: A214370's Return on Equity is forecast to be low in 3 years time (18.7%).